Human basic fibroblast growth factor
AssigneesSynergen, Inc., New York University
InventorsDavid A. Moscatelli, Daniel B. Rifkin, Andreas Sommer
Life of this patent
Estimating the term…
Abstract
An angiogenic factor is disclosed which is a purified, single-polypeptide-chain protein having at least one active site possessing an activity selected from the group consisting of mitogenic activity, chemotactic activity, the ability to stimulate protease synthesis and combinations thereof. This angiogenic factor exhibits substantial homology to and is immunologically equivalent to the native angiogenic factor isolatable from human placental tissues. The amino acid sequence of this angiogenic factor is also disclosed. In addition, a method for isolation of the purified angiogenic factor from human placental tissues is set forth. Pharmaceutical preparations incorporating this angiogenic factor are described.
Claims1
An angiogenic factor protein comprising a single-polypeptide-chain protein having at least one active site possessing mitotic and chemotactic activity and the ability to stimulate protease synthesis, wherein said protein is substantially free of the other proteins which are not angiogenic factors and said protein consists of the amino acid sequence:
- ##STR9##
Dependencies are inferred from the claim text.